Article, 2024

Increased risk of nonmelanoma skin cancer in patients with alpha‐1 antitrypsin deficiency: A nationwide cohort study

Journal of the European Academy of Dermatology and Venereology, ISSN 1468-3083, 0926-9959, 10.1111/jdv.20040

Contributors

Korsbæk, Nanna J 0000-0003-0241-9967 [1] [2] Landt, Eskild Morten 0000-0002-3426-4819 [1] Marott, Sarah [1] Nordestgaard, Børge Grønne 0000-0002-1954-7220 [2] [3] Vinding, Gabrielle Randskov 0009-0004-4485-702X [4] Jemec, Gregor Borut Ernst 0000-0002-0712-2540 [2] [4] Dahl, Morten 0000-0002-6686-312X (Corresponding author) [1] [2] [3]

Affiliations

  1. [1] Zealand University Hospital
    2. [NORA names: Region Zealand; Hospital; Denmark; Europe, EU; Nordic; OECD];
  2. [2] University of Copenhagen
    3. [NORA names: KU University of Copenhagen; University; Denmark; Europe, EU; Nordic; OECD];
  3. [3] Copenhagen University Hospital
    4. [NORA names: Capital Region of Denmark; Hospital; Denmark; Europe, EU; Nordic; OECD];
  4. [4] Zealand University Hospital Roskilde
    5. [NORA names: Region Zealand; Hospital; Denmark; Europe, EU; Nordic; OECD]

Keywords

alpha 1, alpha-1 antitrypsin deficiency, antitrypsin deficiency, cancer, cohort study, deficiency, increased risk, increased risk of nonmelanoma skin cancer, nationwide cohort study, nonmelanoma skin cancer, patients, risk of nonmelanoma skin cancer, skin cancer, study

Funders

  • Novo Nordisk Foundation
  • Novo Nordisk (Denmark)
  • Alpha-1 Foundation

Data Provider: Digital Science

LINKS
-

Matching Records in NORA

SUBJECTS
+

METRICS
+